Premium
Tyra Biosciences Inc (TYRA)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Institution | 12 198 625 | 20,51% | US$ 331,56M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 10 259 291 | 17,25% | US$ 278,85M | 2026-03-04 |
| FMR LLC | Institution | 7 747 629 | 13,03% | US$ 210,58M | 2026-03-31 |
| Nextech Invest Ltd. | Institution | 4 055 861 | 6,82% | US$ 110,24M | 2026-03-31 |
| Nextech IV Oncology S.C.S. SICAV-SIF | Institution | 4 055 861 | 6,82% | US$ 110,24M | 2024-09-30 |
| Janus Henderson Group plc | Institution | 3 890 589 | 6,54% | US$ 105,75M | 2026-03-31 |
| Alta Partners Nextgen Fund II, L.P. | Institution | 3 823 425 | 6,43% | US$ 103,92M | 2025-12-19 |
| Alta Partners LP | Institution | 3 823 425 | 6,43% | US$ 103,92M | 2026-03-31 |
| Farallon Capital Management, L.L.C. | Institution | 3 580 818 | 6,02% | US$ 97,33M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 3 248 980 | 5,46% | US$ 88,31M | 2026-03-31 |
| The Column Group, LLC | Institution | 2 898 103 | 4,87% | US$ 78,77M | 2025-02-27 |
| TCG Crossover Fund I, L.P. | Institution | 2 898 103 | 4,87% | US$ 78,77M | 2025-02-27 |
| Commodore Capital Master LP | Institution | 2 750 000 | 4,62% | US$ 74,75M | 2025-05-07 |
| Commodore Capital LP | Institution | 2 475 000 | 4,16% | US$ 67,27M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2 217 747 | 3,73% | US$ 60,28M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 2 054 991 | 3,46% | US$ 55,85M | 2026-03-31 |
| BVF Partners L.P. | Institution | 1 976 196 | 3,32% | US$ 53,71M | 2026-03-31 |
| RA Capital Nexus Fund, L.P. | Institution | 1 496 613 | 2,52% | US$ 40,68M | 2026-03-04 |
| Farallon Capital Offshore Investors II, L.P | Institution | 1 452 596 | 2,44% | US$ 39,48M | 2026-03-31 |
| Dr. Todd Harris | Initiés | 1 358 631 | 2,28% | US$ 36,93M | 2026-05-05 |
| Caligan Partners, LP | Institution | 1 276 968 | 2,15% | US$ 34,71M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 216 078 | 2,04% | US$ 33,05M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1 135 053 | 1,91% | US$ 30,85M | 2025-12-31 |
| Vanguard Capital Management, LLC | Institution | 1 125 970 | 1,89% | US$ 30,60M | 2026-03-31 |
| 5AM Venture Management, LLC | Institution | 1 029 298 | 1,73% | US$ 27,98M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 986 061 | 1,66% | US$ 26,80M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 850 000 | 1,43% | US$ 23,10M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 829 908 | 1,40% | US$ 22,56M | 2025-12-31 |
| Barclays PLC | Institution | 808 077 | 1,36% | US$ 21,96M | 2026-03-31 |
| Canaan Management, Inc. | Institution | 750 000 | 1,26% | US$ 20,39M | 2026-03-31 |
| Canaan XI | Institution | 750 000 | 1,26% | US$ 20,39M | 2026-03-31 |
| Farallon Capital Institutional Partners, L.P. | Institution | 739 107 | 1,24% | US$ 20,09M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 658 482 | 1,11% | US$ 17,90M | 2026-03-31 |
| Jennison Associates LLC | Institution | 632 432 | 1,06% | US$ 17,19M | 2026-03-31 |
| Sio Capital Management, LLC | Institution | 605 439 | 1,02% | US$ 16,46M | 2026-03-31 |
| Farallon Capital Partners, L.P. | Institution | 579 376 | 0,97% | US$ 15,75M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 549 000 | 0,92% | US$ 14,92M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 526 604 | 0,89% | US$ 14,31M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 351 479 | 0,59% | US$ 9,55M | 2026-03-31 |
| Elmind Capital, L.P. | Institution | 350 000 | 0,59% | US$ 9,51M | 2026-03-31 |
| Woodline Partners LP | Institution | 301 040 | 0,51% | US$ 8,18M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
